Vassiliki Saloura

AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

Toni M. Brand, Mari Iida, Andrew P. Stein et al. · Clinical Cancer Research · 2015 · 117 citations · Full text

Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma

Candice Willmon, Vassiliki Saloura, Zvi G. Fridlender et al. · Cancer Research · 2009 · 110 citations · Full text

WHSC1 Promotes Oncogenesis through Regulation of NIMA-Related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck

Vassiliki Saloura, Hyun‐Soo Cho, Kazuma Kiyotani et al. · Molecular Cancer Research · 2014 · 99 citations · Full text

An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck

Vassiliki Saloura, Ezra E.W. Cohen, Lisa Licitra et al. · Cancer Chemotherapy and Pharmacology · 2014 · 85 citations

Phase Ii Trial, Malignant Disease, Open-label Single-arm +9

Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-β for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy

Vassiliki Saloura, Liang-Chuan S. Wang, Zvi G. Fridlender et al. · Human Gene Therapy · 2009 · 72 citations · Full text

Mesothelioma Cell Lines, Malignant Pleural Mesothelioma, Molecular Virology +15